Company
Headquarters: Alachua, FL, United States
Founded: January 19, 1999
Employees: 83
CEO: Ms. Susan B. Washer
$26.6 Million
USD as of Nov. 1, 2022
Company | Market Cap (USD) |
---|---|
Novo Nordisk | $461.52 B |
Vertex Pharmaceuticals Incorporated | $107.23 B |
Regeneron Pharmaceuticals, Inc. | $100.01 B |
CSL Limited | $94.74 B |
Marinomed Biotech AG | $73.23 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Applied Genetic Technologies Corporation has the following listings and related stock indices.
Stock: NASDAQ: AGTC wb_incandescent
Stock: FSX: 2GT wb_incandescent
Susan B. Washer (President & CEO) William A. Sullivan (CFO)
Revenue: US$ 24.19 million(FY JUN 30, 2018)
Operating income: US$ -22.38 million(FY JUN 30, 2018)
Net income: US$ -21.30 million(FY JUN 30, 2018)
Total assets: US$ 118.53 million(FY JUN 30, 2018)
Total equity: US$ 99.18 million(FY JUN 30, 2018)